Navigation Links
Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
Date:9/11/2007

DEERFIELD, Ill., Sept. 11 /PRNewswire/ -- Takeda Pharmaceuticals North America, Inc. is aware of the review of ACTOS(R) (pioglitazone HCl) data conducted by A. Michael Lincoff, M.D., and colleagues at the Cleveland Clinic, published in the Journal of the American Medical Association which concluded that ACTOS is associated with a significantly lower risk of heart attack, stroke, or death among a diverse population of 16,390 patients with diabetes versus control therapy.

This new meta-analysis is consistent with the depth and breadth of ACTOS cardiovascular data: ACTOS studies, conducted over the past 10 years, including short- and long-term trials, as well as prospective and observational studies, have shown no evidence that ACTOS is associated with an increased risk of heart attack, stroke, or death.

Meta-analyses are pooled data across a number of studies. Although not definitive, they can offer insight into aspects of a compound or product that may not be readily available from individual studies. The overall effect calculated from a group of like or similar randomized trials can provide an estimate of the drug's overall effects in an expanded population.

This meta-analysis adds important information to the body of evidence regarding ACTOS and macrovascular ischemic events, and further documents the consistency of data from prospective studies, to meta-analysis, to observational studies.

Critical in this body of data is PROactive (PROspective PioglitAzone Clinical Trial In MacroVascular Events), a trial of patients with type 2 diabetes who are at high risk for cardiovascular events. Results from this prospective, randomized, placebo-controlled outcomes trial -- considered by scientists to be the most scientifically rigorous type of study -- were reviewed by the FDA and added to the ACTOS label. These data show no increase in mortality or total macrovascular events with ACTOS. ACTOS is the only thiazolidinedione (TZD) with safety dat
'/>"/>

SOURCE Takeda Pharmaceuticals North America, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Merck and Takeda to collaborate in the sale of Cancer drug Matuzumab
2. Largest Ever Study of Genetics Behind Common Diseases Published
3. A Just Published Book Promises To Guide Women Regarding Their Frequent UTI’
4. Findings on Dangerous Parasite, Toxoplasma Gondii Published
5. Siddha Medicine Texts to Be Published in English
6. Journal Recommends How To Improve The Performance Of Health Workers
7. Medical Journals should create awareness on Child survival
8. A journal’s report on stress, among pregnant wome
9. Canadian Medical Association Journals Editorial Mess Gets Murkier
10. Journalists Blamed For Bird Flu Spread Across Israel
11. Future of Canadian Medical Association Journal Threatened
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... 14, 2014 The report “Intelligent ... [Physical Security, Life Safety, Facility Management], IT Technologies ... & Analysis (2014 - 2019)” defines and segments ... in-depth analysis and forecasting of revenues. The report ... restraints and opportunities impacting it, along with the ...
(Date:7/14/2014)... July 14, 2014 This report ... market in Americas. The analysis includes market size ... period and key company share data by revenue ... Brazil and Mexico. It uses data and information ... and in-house analysis. , Scope, ...
(Date:7/14/2014)... The Encino cosmetic dentist at Encino ... and porcelain veneers. These restorations are an excellent alternative ... greater loss of healthy tooth tissue. They work similarly ... on the tooth. Encino dentist Dr. Mastour and his ... they offer the most appropriate treatment recommendations for each ...
(Date:7/14/2014)... -- Being physically active in middle age appears to ... types of dementia, suggest the findings from two new ... exercise at various levels, especially in midlife, is beneficial ... Clinic, said in an Alzheimer,s Association news release. ... conclusive. More research is needed to determine the extent ...
(Date:7/14/2014)... 2014 Follow us ... chromatography or UPLC is a new and ... that involves the use of extremely small-sized ... chromatographic compounds. This highly sensitive qualitative and ... analysis of chromatography samples. UPLC functions on ...
Breaking Medicine News(10 mins):Health News:Intelligent Building Automation Technologies Market Worth $74.8 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Intelligent Building Automation Technologies Market Worth $74.8 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Intelligent Building Automation Technologies Market Worth $74.8 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Americas Transcatheter Heart Valves Market 2020 Forecasts in New Research Report at LifeScienceIndustryResearch.com 2Health News:Americas Transcatheter Heart Valves Market 2020 Forecasts in New Research Report at LifeScienceIndustryResearch.com 3Health News:Americas Transcatheter Heart Valves Market 2020 Forecasts in New Research Report at LifeScienceIndustryResearch.com 4Health News:Encino Esthetic Dental Group is Now Offering Lumineers and Porcelain Veneers 2Health News:Staying Active May Help Prevent Dementia 2Health News:Need for Faster Sample Analysis Drives Demand for UPLC, According to New Trend Report Published by Global Industry Analysts, Inc. 2
... , , WASHINGTON , Feb. 8 ... showed he has what it takes to win big. Not only does ... own Milk Mustache. The 13th annual winning football Milk Mustache ad runs ...   http://www.newscom.com/cgi-bin/prnh/20100208/AQ51302 ) , The famed running back is the latest superstar ...
... Nev. , Feb. 8 The Whittemore Peterson ... Donnica Moore , a distinguished women,s health expert, as its ... in its efforts to help raise awareness and funding for ... Fatigue Syndrome.   , "We are pleased to have a ...
... ... Health, a joint venture between Humility of Mary Health Partners (HMHP) , NEO ... Ohio,s first and only radiation oncology center with Elekta Volumetric Modulated Arc Therapy (VMAT), ... ...
... , , NORTHBROOK, Ill. , ... a global leader in environmental evaluation and certification, announces ... materials used in consumer and manufactured goods.  These standards ... scientific assessment and broad stakeholder collaboration.   , This ...
... the use of computed tomography (CT scans) in children ... of scans, according to a new study in ... link only) http://www.cmaj.ca/embargo/cmaj091421.pdf . More than 650,000 ... consciousness, amnesia, disorientation and/or vomiting are seen each year ...
... JRS Medical ... that the Company is donating a percentage of all of their January & February 2010 ... employees also are raising funds locally for victims of the tragic earthquake. , ... (PRWEB) February 8, 2010 -- JRS Medical ...
Cached Medicine News:Health News:Reggie Bush Takes Down Reggie Wayne in Battle for the Milk Mustache! 2Health News:Whittemore Peterson Institute Announces Renowned Health Expert as New Spokesperson 2Health News:Partners for Urology Health First in Ohio with New Radiation Therapy Technology 2Health News:Partners for Urology Health First in Ohio with New Radiation Therapy Technology 3Health News:UL Environment to Develop Sustainability Standards For Plastic 2Health News:New CATCH rule to determine need for CT scans in children with minor head injury 2Health News:JRS Medical Raises Funds for Devastated Victims in Haiti 2Health News:JRS Medical Raises Funds for Devastated Victims in Haiti 3
(Date:7/14/2014)... , July 14, 2014  Remedy Informatics, the ... healthcare delivery and life sciences research, announced that ... Foundation (NPF) to build the first-ever national patient ... cancer and pancreatitis. "The National Pancreas ... change that thoughtful and committed organizations can effect ...
(Date:7/14/2014)... , July 14, 2014 Valeant ... and TSX: VRX) today announced it has filed ... Act of 1976 (HSR) with the U.S. Federal ... of Allergan, Inc. (NYSE: AGN). ... Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a ...
(Date:7/14/2014)...  Diomics, Inc., provider of X-Swab™, a novel ... States Patent and Trademark Office has issued two ... sample collection materials, devices made from them, and ... The primary method of collecting ... DNA from a number of commercially-available swabs is ...
Breaking Medicine Technology:Remedy Informatics Partners with National Pancreas Foundation to Build a National Patient Registry 2Remedy Informatics Partners with National Pancreas Foundation to Build a National Patient Registry 3Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 2Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 3Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 4Valeant Pharmaceuticals Submits HSR Filing Relating To Proposed Acquisition Of Allergan 5Diomics Announces Issuance Of U.S. Patents For Novel Biologic Sample DNA Collection Materials For Use In Forensics And Diagnostics 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: